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PeroxisomeProliferator-ActivatedReceptors(PPARs)weredis-
covered by Isseman and Green in 1990 [1]. Since this time
PPARs have been demonstrated to play a major role in a di-
verse group of processes and pathological conditions associ-
ated with aging [2, 3], inﬂammation [4, 5], immunity [6],
obesity [7], diabetes [8], cancer [9], and fertility [10, 11].
In the short period since their discovery, interest in the
functioning of the PPAR receptors has greatly intensiﬁed,
and studies of the biology of the PPARs have become abun-
dant. Accordingly, the number of publications in this ﬁeld
has undergone exponential growth, climbing from less than
100 published articles in 1995 to more than 1600 articles in
2005; continued growth is to be expected. Of further impor-
tance, the PPARs have entered directly into the clinical arena.
Drugs which activate PPARs are currently used clinically to
treat diabetes, and others are also undergoing clinical trials
as anti-inﬂammatory agents.
PPAR Research is designed to be a much needed, open
access forum dedicated to the publication of original, high-
quality, peer-reviewed articles on the advances in basic
research, preclinical studies, and clinical trials involving
PPARs, and their obligatory heterodimer partners, retinoid-
X receptors. This Journal will provide a unique venue to
bringtogetheradiversescopeofstudiesandwilloﬀertoboth
scientists and clinicians working in this ﬁeld of study the op-
portunity to learn of the latest discoveries in areas other than
their own.
PPAR Research also intends to illustrate the magnitude
and signiﬁcance of this discipline by bringing into focus the
diversity of areas of study involved in PPAR research. This
w i l ls u r e l yp r o m o t ei n t e r e s ti na sw e l la se n h a n c e du n d e r -
standingofthiscriticalﬁeldofresearchbythescientiﬁccom-
munity at large.
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